EUVIMEDEUVIMED entdecken
Open Access

Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients

Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, Katsuhiko Masudo, Ai Matsui, Aya Saito

Endocrine Journal · 2026 · 73 (9) · 1045-1054

DOI: 10.1507/endocrj.ej25-0629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Haruhiko Yamazaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa 232-0024, Japan. Hauptthemen laut MEDLINE: Pyridones, Oximes, Imidazoles, Pyrimidinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesOximesImidazolesPyrimidinonesProto-Oncogene Proteins B-rafThyroid NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleMiddle AgedAgedMutationAdultTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

Advanced thyroid carcinomaBRAF mutationDabrafenibPrognosisTrametinib

Substanzen

PyridonesOximestrametinibdabrafenibImidazolesPyrimidinonesProto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa 232-0024, Japan.
  • Department of Surgery, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan.
  • Department of Endocrine Surgery, Kanagawa Cancer Center, Kanagawa 241-8515, Japan.

Zitieren

APA

Yamazaki, H., Suganuma, N., Kadoya, M., Masudo, K., Matsui, A., & Saito, A. (2026). Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients. Endocrine Journal, 73(9), 1045-1054. https://doi.org/10.1507/endocrj.ej25-0629

Vancouver

Yamazaki H, Suganuma N, Kadoya M, Masudo K, Matsui A, Saito A. Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients. Endocrine Journal. 2026;73(9):1045-1054. doi:10.1507/endocrj.ej25-0629

BibTeX
@article{Yamazaki2026,
  author = {Yamazaki, Haruhiko and Suganuma, Nobuyasu and Kadoya, Mei and Masudo, Katsuhiko and Matsui, Ai and Saito, Aya},
  title = {Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients},
  journal = {Endocrine Journal},
  year = {2026},
  volume = {73},
  number = {9},
  pages = {1045--1054},
  doi = {10.1507/endocrj.ej25-0629}
}
Kostenlos starten →